Kristy Richards ’90 came to the Cornell University College of Veterinary Medicine (CVM) with a vision — study canine cancer patients to improve treatments for both dogs and humans.
Kristy Richards '90, a groundbreaking cancer researcher and associate professor of biomedical sciences.
As a human oncologist, Richards came to CVM with the aim of recruiting canine lymphoma patients for novel therapeutics, including immunotherapy, and using those results to better inform both veterinary and human medicine.
The approach was trailblazing, just like its champion — Richards arrived at Cornell with fanfare, establishing ties with Weill Cornell Medicine and a novel facility designed to create cutting-edge cancer research tools.
Tragically, in 2019, Richards passed away, putting a devastating halt to her comparative cancer research.
“Kristy was such an effective driver of this project — when she passed it was really hard,” says Dr.
Robert Weiss, a colleague of Richards.
“But we were all committed to seeing it through, to see her tools benefit the scientific community.” That commitment has come to fruition with a new collaborative study published Sept.
It details the successful creation of three new patient-derived xenograft (PDX) models and two stable cell lines from naturally occurring canine B-cell lymphoma tumors, using samples collected from pet dogs diagnosed with the disease.
“This is a true continuation of what Kristy was trying to do,” says Weiss, who is one of the authors on the paper, along with many colleagues at CVM and Weill Cornell Medicine.
“Creating new resources for more effectively treating diseases in both pets and people.
The report adds to ongoing university-led research relevant to veterinary medicine, animal health, and clinical decision-making.
university website: Cornell University College of Veterinary Medicine


Join this discussion
Add your reply
Share a professional insight, ask a focused question, or add relevant clinical experience.
Member participation
Log in to join the discussion
Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.